Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 119, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2023.110163
Keywords
Rheumatoid arthritis; Casein kinase 2; CX-4945; Fibroblast-like synoviocytes; p53 signaling pathway
Categories
Ask authors/readers for more resources
Fibroblast-like synoviocytes (FLS) play important roles in the pathological processes of rheumatoid arthritis (RA). CK2, elevated in RA FLS, was found to be associated with abnormal phenotypes. Targeted inhibition of CK2 using CX-4945 suppressed RA FLS proliferation, migration, and invasion, and reduced inflammation-related factors secretion. Further investigation revealed that CX-4945 can alleviate the severity of RA by modulating the p53 signaling pathway.
Fibroblast-like synoviocytes (FLS) mediate many pathological processes in rheumatoid arthritis (RA), including pannus formation, bone erosion, and inflammation. RA FLS have unique aggressive phenotypes and exhibit several tumor cell-like characteristics, including hyperproliferation, excessive migration and invasion. Casein kinase 2 (CK2) is reportedly overexpressed in numerous tumor types, and targeted inhibition of CK2 has ther-apeutic benefits for tumors. However, the expression level of CK2 and its functions in RA FLS remain unclear. Herein, we aimed to elucidate whether CK2 is responsible for the aggressive phenotypes of RA FLS and whether targeted therapy can alleviate the severity of RA. We found that CK2 subunits were elevated in RA FLS compared with osteoarthritis FLS, and the activity of CK2 also markedly increased in RA FLS. Targeted inhibition of CK2 using CX-4945 suppressed RA FLS proliferation through cell cycle arrest. Cell migration and invasion were also inhibited by CX-4945 treatment. Moreover, CX-4945 reduced Interleukin-6 (IL-6), C-C motif chemokine ligand 2 (CCL2) and Matrix metalloproteinase-3 (MMP-3) secretion in RA FLS. Further proteomic investigation revealed that p53 signaling pathway significantly changes after CX-4945 treatment in RA FLS. The siRNA-mediated p53 knockdown partly abolished the anti-proliferation and reduced IL-6, MMP-3 secretion effects of CX-4945. Furthermore, CX-4945 administration alleviates arthritis severity in CIA mice. Collectively, our results demon-strated the abnormal elevation of CK2 and its positive association with abnormal phenotypes in RA FLS. Our novel findings suggest the possible therapeutic potential of CX-4945 for RA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available